Search

Your search keyword '"Coupier, Isabelle"' showing total 317 results

Search Constraints

Start Over You searched for: Author "Coupier, Isabelle" Remove constraint Author: "Coupier, Isabelle"
317 results on '"Coupier, Isabelle"'

Search Results

1. Psychological and ethical issues raised by genomic in paediatric care pathway, a qualitative analysis with parents and childhood cancer patients

2. Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease

3. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

4. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

5. Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation

7. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers

8. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

11. ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors

12. Data from Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

13. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

14. Supplementary Tables 1-4 from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

15. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

16. Data from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

17. Supplementary Data from Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

18. The “extreme phenotype approach” applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles

19. Early onset breast cancer: differences in risk factors, tumor phenotype, and genotype between North African and South European women

20. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

22. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers

23. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

24. Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma

26. Association and Performance of Polygenic Risk Scores for Breast Cancer Among French Women Presenting or Not a Familial Predisposition to the Disease

28. A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

29. Variation in the Risk of Colorectal Cancer for Lynch Syndrome: A retrospective family cohort study

30. Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith–Wiedemann Syndrome: Clinical Spectrum and Functional Characterization

31. A germline mutation in PBRM1 predisposes to renal cell carcinoma

32. TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing

33. No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families

34. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

35. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

36. Additional file 1 of Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation

37. Additional file 2 of Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation

38. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

39. Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers:an international cohort study

40. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

41. Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)

42. High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome

43. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of DICER1 syndrome

44. Brief report: High prevalence of somatic oncogenic driver alterations in non-small cell lung cancer patients with Li-Fraumeni Syndrome

45. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

46. RAD51 135G C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies

47. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

48. BAP1 and Breast Cancer Risk

49. Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility

Catalog

Books, media, physical & digital resources